What is LKFT's P/E ratio?

LAKEFRONT BIOTHERAPEUTICS NV (LKFT) currently trades at a P/E ratio of 2.29.

LAKEFRONT BIOTHERAPEUTICS NV reports a Return on Equity (ROE) of 15.02%.

What is LKFT's dividend yield?

LAKEFRONT BIOTHERAPEUTICS NV offers a dividend yield of 0.00%.

What is LKFT's Deepscope Quality Score?

Deepscope rates LKFT's overall financial quality at 85 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy LKFT?

Deepscope's AI Timing Score for LKFT is 76 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does LKFT belong to?

LAKEFRONT BIOTHERAPEUTICS NV is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

หุ้น LKFT (NASDAQ) | LAKEFRONT BIOTHERAPEUTICS NV – วิเคราะห์โดย Deepscope

Stock Check ข้อมูลอัปเดตรายวัน ที่เวลา 09.30 น.
(Price: 2026-06-05 | FS: 2026-03-31)

LKFT

LAKEFRONT BIOTHERAPEUTICS NV

US:NASDAQ STOCK Healthcare >> Biotechnology News 79

USD 28.02

-0.09 (-0.32%) Day Change

Watchlist Portfolio Compare Chart

2.29

P/E

0.00

D/E

15.0%

ROE

14.5%

ROA

0.00%

Div Yield

0.10

PEG

LAKEFRONT BIOTHERAPEUTICS NV
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 28.02 Price -0.09 (-0.32%) Day Change	NEWS SCORE: 79

LKFT มีคุณภาพโดยรวมดีมาก ( คะแนนปัจจัยพื้นฐาน = 85) และ จังหวะเข้าซื้อ ...(ล็อกอินเพื่อดู)...

No price data to display chart for the last 3-months of this stock

85 QUALITY

Signal: OUTPERFORM

Signal Description: Company financial health is Good

Reason: อัตราผลตอบแทนผู้ถือหุ้น (ROE) ในอดีต ค่อนข้างต่ำ
อัตราเร่งของการเติบโตของอัตรากำไรสุทธิ ต่ำกว่าเกณฑ์

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

ถ้าดูอย่างละเอียดจะพบว่า ปัจจัยทางคุณภาพ พอใช้ สุขภาพทางการเงิน ไม่ดี และ ประสิทธิภาพการทำกำไร พอใช้ , ...

ปัจจัยทางคุณภาพ

63%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	79
Magic Formula Rank by ROA	168
Magic Formula Rank by ROE	168
Magic Formula Rank by ROIC	54 GOOD
Price	28.02
PBV / Sector	0.56 / 4.63 GREAT
Earning Per Share	7.50

PE / Sector	2.29 / 17.43 GREAT
PEG or PE/Growth / Sector	0.10 / 0.53 GREAT
Average 1M Daily Value	4.97 M GREAT
Average 1W Daily Value	6.55 M

ปัจจัยทางเทคนิค

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

สุขภาพทางการเงิน

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ประสิทธิภาพการทำกำไร

68%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	46.83 / 449.48 GREAT
NPM Average (%) / Sector	20.10 / -1,506.49 GREAT
NPM Change Average (%) / Sector	-49.41 / 4,940.99
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	14.49 / 30.58
ROA Average (%) / Sector	5.19 / -347.17
ROA Change Average (%) / Sector	52.77 / 5,125.52 GREAT
ROE (%) / Sector	15.02 / -3.58
ROE Average (%) / Sector	5.29 / 40.65
ROE Change Average (%) / Sector	21.33 / 2,109.80 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

ผลตอบแทนต่อผู้ถือหุ้น

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.17

รายละเอียดการจดทะเบียน

Analyze Date	2026-06-06 09:08:42
Symbol	LKFT
Name	LAKEFRONT BIOTHERAPEUTICS NV
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	65.90 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,825.35 / 8,857.28

ข่าว, ประมาณการ, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: SchaliEnhoevedreef 20 T, Mechelen, Belgium, 2800

Phone: 32 1 534 29 00

Website: https://lakefrontbio.com

Employees: -

Sector: Healthcare >> Biotechnology

Description: Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was formerly known as Galapagos NV and changed its name to Lakefront Biotherapeutics NV in May 2026. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.